SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN)
ALXN 182.500.0%Jul 28 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: kenhott2/4/2008 8:56:51 PM
   of 824
 
Form 8-K for ALEXION PHARMACEUTICALS INC

4-Feb-2008

Other Events

Item 8.01 Other Events.

On January 31, 2008, SB2, Inc. filed a civil action against Alexion Pharmaceuticals, Inc. in the U.S. District Court for the Northern District of California. SB2, Inc. claims willful infringement by Alexion of SB2, Inc. patents. SB2, Inc. seeks, among other things, monetary damages and equitable relief.

+++++++++++++++++++
SB2, a private company into licensing antibody patents. Headed by Fildes, Pres of Cetus before Chiron's $600mish buyout. Poor guy missed the buyout by a couple of hairs. The board kicked him out after the FDA bomb. After all the infighting he did, he needed the FDA decision and the FDA was not his friend. Then he ran two bio companies into the ground, like eating potato chips, one after another (was there a rest period?). Which in my opinion is a lil amazing because it is not that easy to kill a biotech.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext